Central catheter-related Gordonia bronchialis bacteremia – Full Text
“This article reports an acute myeloid leukemia (AML) case in which the patient developed febrile neutropenia and was later found to have Gordonia bronchialis (G. bronchialis) CLABSI” Alnajjar et al (2023).
Prevention of hemodialysis CRBSI
“We aimed to determine whether multifaceted quality improvement interventions in hemodialysis units can prevent hemodialysis catheter-related bloodstream infections (HDCRBSI)” Lazarus et al (2023).
Removal of stuck implantable port catheter
“Port-based central venous catheters may remain indwelling for years with subsequent fibrosis resulting in a “stuck” catheter. At time of removal, this can lead to complications such as catheter fracture or require additional operative techniques for safe extraction” Urevick et al (2023).
Central catheter fragment caused ventricular fibrillation – Full Text
“Physicians failed to remove the foreign body using catheter therapy, and ventricular fibrillation occurred repeatedly. After induction of general anesthesia, the fractured catheter was removed surgically” Takahashi et al (2023).
Thromboembolism risk factors in children with CVC
“The findings of this study provide new insights on risk factor differences between CRT and non-CRT. Prevention efforts should be directed at modifying the type of CVC, insertion location and/or number of CVCs placed if possible, to decrease the incidence of CRT” Jaffray et al (2023).
Arterial injuries following central venous catheterization
“Inadvertent supra-aortic arterial injuries during central venous catheterization can lead to devastating outcomes. These have been traditionally been managed with open repair or covered stent placement; only recently have percutaneous closure been incorporated into the management of these iatrogenic arterial injuries” Kania et al (2023).
Review of paramedic insertion of peripheral intravenous catheters
“This is the first Australian state-wide study to report unused paramedic-inserted PIVC rates. As 44% remained unused, clinical indications guidelines and intervention studies to reduce PIVC insertion are warranted” Golling et al (2023).
CLABSI in patients with hematologic malignancy receiving parenteral nutrition
“PN was not associated with increased risk of CLABSI in a sample of patients with hematologic malignancy with central venous catheters when adjusting for cancer type, duration of neutropenia, and catheter days” Lazarow et al (2023).
Survey of oncology pharmacy practice in the United States – Full Text
“These results describe the practice landscape of oncology pharmacy at US healthcare institutions to serve as a foundation for future research evaluating metrics and benchmarks” Griffin et al (2023).
Short axis in-plane ultrasound-guided for internal jugular vein access
“The short axis in-plane view technique for central venous line placements allows for real-time US-guided needle venipuncture with simultaneous visualization of surrounding structures” Cheong et al (2023).
Nurses experience of CVAD-related thrombosis in hospitalized children
“The purpose of this study was to elaborate on the level and influencing factors of pediatric nurses’ knowledge, attitude, and practice on the prevention related to CRT in hospitalized children” Tian et al (2023).
Central venous catheter type overview
“This review gives a basic overview of the differences of CVC catheters including PICCs, Hickman-catheters and port-catheters along with the criteria for CVC selection” Kehagias et al (2023).
Catheter-related UEDVT recurrence in cancer patients
“Catheter-related thrombosis (CRT) occurs in approximately 2-6% of cancer patients. We conducted a single-center retrospective study to assess the rate of venous thromboembolism (VTE) recurrence in cancer patients; 200 patients were included” Hakem et al (2023).
Vascular access device options in breast cancer patients – Full Text
“The aim of this study was to assess the cost-effectiveness of three catheters for long-term chemotherapy in breast cancer patients” Chen et al (2023).
Hand motion analysis associated with ultrasound-guided procedures
“To evaluate the ability of hand motion analysis using conventional and new motion metrics to differentiate between operators of varying levels of experience for central venous access (CVA) and liver biopsy (LB)” Weinstein et al (2023).
Hemodialysis vascular access coordinator
“The vascular access coordinator can positively contribute to increase the number of arteriovenous fistulas and reduce central venous catheters” Sousa et al (2023).
Heparin and saline comparison for CVC occlusion prevention
“Considering the potential risks of heparin, the use of normal saline flushing may be recommended to prevent CVC obstruction” Semerci et al (2023).
Impact of multiple peripheral IV insertions on low-birth-weight infants
“It is necessary to develop preventive measures to reduce the impact of multiple insertions to establish peripheral intravenous access in LBW infants” Handayani and Efendi (2023).
GAVeCeLT consensus for venous access in newborns – Full Text
“The goal of the present consensus is to offer a systematic set of recommendations on the choice of the most appropriate vascular access device in Neonatal Intensive Care Unit” Barone et al (2023).
Tunneling technique for central venous access devices in neonates
“In our experience, the CTA tunneling technique is reliable, safe, and feasible in the neonate even from the first hours of life, as well as for preterm newborns; it could be a valid alternative to the usual exit site” Rodriguez Perez et al (2023).
Early switch from IV to oral antibiotic treatment in bone infections
“The timing of the switch from intravenous (IV) to oral antibiotic therapy for orthopaedic bone and joint infections (BJI) is debated. In this narrative article, we discuss the evidence for and against an early switch in BJIs” Sendi et al (2023).
Peripheral venous catheter-related bloodstream infection – Full Text
“In this study, we report the case of a 14-month-old female patient transferred from another hospital to our hospital with a 9-day history of fever and worsening dyspnea” Ochi et al (2023).
HAI bundle compliance results – Full Text
“Compliance rates were 94%, 100%, 99%, and 76% for ventilator-associated pneumonia, central line-associated bloodstream infections, catheter-associated urinary tract infections, and hand hygiene bundles, respectively” Alrebish et al (2023)
OPAT experience of ceftolozane and tazobactam – Full Text
“C/T was successfully used in the outpatient setting to treat a variety of serious infections with a high prevalence of resistant pathogens” Van Anglen et al (2023).
Early identification of local infections in central venous catheters – Full Text
“Definitions of local CVC infections are highly heterogeneous in the revised literature. It is necessary to establish a consensus regarding the definitions of hemodialysis CVC exit site and tunnel infections” Cobo-Sánchez et al (2023).
Sedation during PICC insertion in children – Full Text
“For sedating burn children, nasal dripping of dexmedetomidine is both safe and effective during PICC inserting” Lu et al (2023).
Vasopressor administration through a midline catheter
“We found no significant association of vasopressor administration though a midline with catheter-related complications. However, we identified an increased odds of systemic (but not ipsilateral upper extremity) venous thromboembolism warranting further evaluation” Gershengorn et al (2023).
Managing opioid waste in the emergency department
“In this study, we sought to utilize real-world data to describe the magnitude of morphine and hydromorphone waste in the studied EDs. We also applied scenario analyses based on provider ordering patterns to simulate the effects of cost versus opioid waste minimization when making purchasing decisions for the dose of stock vial of each opioid” Coleska et al (2023).
Dialkylcarbamoylchloride IV dressing in pediatrics – Full Text
“Dialkylcarbamoylchloride dressing is well-tolerated in paediatric and neonatal population. It represents a promising tool as a strategy for infection prevention” Lamberti et al (2023).
Dalbavancin in patients unsuitable for OPAT
“Dalbavancin offers similar clinical outcomes to SOC for patients with SAB who are unable to receive OPAT” Frazier et al (2023).